Back to articles
Comparative guide · 6 min read

Curcumin vs Ginger for inflammation — what each does in pain, OA, and metabolic markers

Updated 2026-05-15 · Reviewed by SupplementScore editors · No sponsorships

Curcumin and ginger are botanical cousins (both Zingiberaceae rhizomes) marketed for similar "anti-inflammatory" claims. The trial portfolios are not identical: curcumin has the larger and cleaner dataset in knee osteoarthritis and metabolic markers; ginger has stronger evidence in nausea, primary dysmenorrhea, and exercise-induced soreness. Both have absorption problems that the supplement industry has tried to solve with varying success.

Quick verdict

GoalBetter choiceWhy
Knee osteoarthritis painCurcuminMeta-analyses show curcumin formulations comparable to NSAIDs on WOMAC scores; ginger has weaker OA data.
Pregnancy or chemotherapy nauseaGingerThe Cochrane review supports ginger for chemotherapy-induced and pregnancy nausea at 1–1.5 g/day.
Primary dysmenorrheaGingerSeveral RCTs at 750–2000 mg/day ginger powder match NSAIDs on menstrual pain.
DOMS / exercise-induced sorenessGingerMeta-analyses support ginger 2 g/day for reducing post-exercise muscle pain.
Metabolic / lipid / HbA1c markersCurcuminLarger meta-analyses for fasting glucose, TG, and CRP improvements with curcumin.
Cost at studied doseGinger (powder/food form)Ginger powder is essentially free; pharmaceutical-grade curcumin (phytosome, BCM-95, Meriva) is $0.50–1.50/day.

How they actually work

Curcumin — NF-κB inhibition with an absorption problem

Curcumin (and its metabolite tetrahydrocurcumin) inhibits NF-κB, TNF-α, IL-6, and COX-2 in vitro. The clinical signal in knee OA is well-replicated: meta-analyses pool 1500–2000 mg of phytosome curcumin or 500 mg b.i.d. of BCM-95 as comparable to ibuprofen 1200 mg/day or diclofenac 100 mg/day on WOMAC pain scores at 4–12 weeks. The catch: native curcumin has 1–5% oral bioavailability. The industry's response — phytosome (Meriva), micellar, BCM-95 (curcuminoid + essential oils), Theracurmin (nanoparticle), liposomal — actually matters. A capsule labelled "1000 mg turmeric" with no formulation language delivers almost no systemic curcumin.

Ginger — gingerols, shogaols, and the nausea receptor story

Ginger's active phenols (6-, 8-, 10-gingerol; 6-shogaol after thermal conversion) inhibit COX-2 and 5-LOX, modestly inhibit thromboxane synthesis, and act on 5-HT3 receptors — the same receptor family that ondansetron targets. The nausea evidence is the cleanest in any botanical: Cochrane and AHRQ reviews support ginger 1–1.5 g/day for pregnancy nausea and chemotherapy-induced nausea. For inflammatory pain endpoints, ginger's signal is real but smaller than curcumin's.

Osteoarthritis — curcumin's home turf

The Daily 2021 meta-analysis (16 RCTs, 1700+ patients) found curcumin comparable to NSAIDs on WOMAC pain and function, with fewer GI adverse events. The Bannuru/Wang series in Annals of Internal Medicine network meta-analyses also place curcumin in the "comparable to NSAIDs" tier for knee OA. Ginger's OA data are smaller (Bartels 2015 systematic review) and less impressive in magnitude.

Nausea, dysmenorrhea, and DOMS — ginger's home turf

Ginger 750–2000 mg/day powder, started 1–2 days before menses and continued through the first 3 days, has 5+ RCTs showing pain reduction comparable to mefenamic acid or ibuprofen on visual analogue scale and Likert scales. Pregnancy nausea: Cochrane supports 1 g/day in divided doses; safe in first trimester per ACOG (Class C "consider"). Chemotherapy nausea: NCCN guidelines include ginger as a complementary option alongside 5-HT3 antagonists. DOMS: Wilson 2015 meta-analysis supports 2 g ginger/day for reducing post-exercise muscle pain at 24 and 48 hours.

Metabolic markers — curcumin slightly ahead

Curcumin meta-analyses (Qin 2017, Sahebkar 2014) show small but significant reductions in fasting glucose, HbA1c, triglycerides, and CRP. Ginger has positive trials on the same endpoints but smaller and less consistent. Neither replaces metformin, statins, or weight loss.

Practical rule. Match the rhizome to the symptom. Knee OA, metabolic markers, or general "anti-inflammatory" support — curcumin in a bioavailable formulation (phytosome, BCM-95, micellar, liposomal). Nausea, period pain, or post-workout soreness — ginger powder 1–2 g/day from food or capsule. Combining them is reasonable; they hit slightly different pathways and the side-effect profiles do not stack badly.

Dose, form, and timing

Curcumin: 500 mg b.i.d. of BCM-95 / Meriva 1 g/day phytosome / Theracurmin 90 mg b.i.d. / liposomal at label dose. Avoid "1000 mg turmeric extract" without formulation language — bioavailability is the rate-limiting variable. Take with a fatty meal. 4–12 weeks before reassessing.

Ginger: 1–2 g/day of powdered ginger root (capsule or food), divided. For nausea: start at 250 mg q.i.d. and titrate. For dysmenorrhea: 250 mg q.i.d. starting 1–2 days before menses. For exercise: 2 g/day continuous or 4 g acute pre-exercise.

Safety

Curcumin: Mild antiplatelet effect — discuss before surgery or alongside anticoagulants. Rare case reports of liver injury (mostly in piperine-enhanced formulations or unstandardised products); discontinue if liver labs rise. Inhibits CYP3A4 modestly — caution with narrow-therapeutic-index drugs. Possible interactions with iron supplements at high doses.

Ginger: Mild antiplatelet effect. GI upset, heartburn at high doses. Theoretical caution with anticoagulants and antiplatelets. Pregnancy: doses up to 1 g/day for nausea well-tolerated; higher doses less established.

Who should pick each

Pick curcumin if: knee OA, RA, metabolic syndrome, or general systemic anti-inflammatory adjunct.

Pick ginger if: nausea (pregnancy, chemotherapy, motion), dysmenorrhea, or post-exercise soreness. Food-form ginger (tea, fresh root) carries no downside and modest upside.

What we'd actually take

For knee OA: BCM-95 500 mg b.i.d. for an 8-week trial alongside weight loss and progressive loading. For period pain: ginger powder 250 mg q.i.d. starting 1–2 days before menses (cheaper and faster than reaching for NSAIDs in many users). For "anti-inflammatory" goals without a specific symptom: rebalance toward Mediterranean dietary pattern and resistance training — they outperform any rhizome.

Sources

Read more: